Patents by Inventor Peter P. Soltesz

Peter P. Soltesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220202467
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 30, 2022
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 11304742
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: April 19, 2022
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20200038086
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: October 2, 2019
    Publication date: February 6, 2020
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 10470811
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: November 12, 2019
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20170258509
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: October 24, 2016
    Publication date: September 14, 2017
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 9486266
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: November 8, 2016
    Assignee: PulmonX Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 9131942
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: September 15, 2015
    Assignee: PULMONX CORPORATION
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20140081308
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Application
    Filed: March 6, 2013
    Publication date: March 20, 2014
    Applicant: Pulmonx Corporation
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20140018605
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: September 20, 2013
    Publication date: January 16, 2014
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 8568403
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: October 26, 2009
    Date of Patent: October 29, 2013
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 8409168
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: April 2, 2013
    Assignee: Pulmonx Corporation
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Patent number: 8177769
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: May 15, 2012
    Assignee: Pulmonx Corporation
    Inventors: Rodney C. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
  • Publication number: 20100280538
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Application
    Filed: June 22, 2010
    Publication date: November 4, 2010
    Applicant: Pulmonx Corporation
    Inventors: Rodney C. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
  • Patent number: 7766895
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: April 12, 2005
    Date of Patent: August 3, 2010
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Anthony D. Wondka, Rodney A. Perkins, Robert Kotmel
  • Publication number: 20100175693
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Application
    Filed: March 24, 2010
    Publication date: July 15, 2010
    Applicant: Pulmonx Corporation
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20100042089
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: October 26, 2009
    Publication date: February 18, 2010
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 7628789
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: December 8, 2009
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 7186259
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: January 26, 2004
    Date of Patent: March 6, 2007
    Assignee: PULMONx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Patent number: 7141046
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: November 28, 2006
    Assignee: Pulmonx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Patent number: 6997918
    Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: February 14, 2006
    Assignee: Pulmonx
    Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch